Table 2.
Conversion table used in Study 1 at Day 0 for determining the initial dose of torasemide# | ||||||
---|---|---|---|---|---|---|
Theoretical dose of furosemide (evaluated by the clinical investigator) | 1 mg/kg, 2 × /day | 2 mg/kg, 2 × /day | 3 mg/kg, 2 × /day | 4 mg/kg, 2 × /day | 5 mg/kg, 2 × /day | |
Initial dosage (Day 0) of the study treatments distributed by the therapist investigator | Furosemidea (Furosemide group) | 1 mg/kg, 2 × /day | 2 mg/kg, 2 × /day | 3 mg/kg, 2 × /day | 4 mg/kg, 2 × /day | 5 mg/kg, 2 × /day |
Torasemideb (Torasemide group) | 0.2 mg/kg, 1 × /day | 0.4 mg/kg, 1 × /day | 0.6 mg/kg, 1 × /day |
Conversion table used in Study 2 at Day 0 for determining the initial dose of torasemide## | ||||||
---|---|---|---|---|---|---|
Theoretical dose of furosemide (evaluated by the clinical investigator) | 1 mg/kg, 2 × /day | 2 mg/kg, 2 × /day | 3 mg/kg, 2 × /day | 4 mg/kg, 2 × /day | 5 mg/kg, 2 × /day | |
Initial dosage (Day 0) of the study treatments distributed by the therapist investigator | Furosemidea (Furosemide group) | 1 mg/kg, 2 × /day | 2 mg/kg, 2 × /day | 3 mg/kg, 2 × /day | 4 mg/kg, 2 × /day | 5 mg/kg, 2 × /day |
Torasemidec (Torasemide group) | 0.2 mg/kg, 1 × /day | 0.3 mg/kg, 1 × /day | 0.4 mg/kg, 1 × /day | 0.5 mg/kg, 1 × /day | 0.6 mg/kg, 1 × /day |
#Follow‐up from Day 0 to Day 84 ± 4 days: if judged necessary by the clinical investigator (depending on the animal's general clinical condition and all parameters recorded at each visit, i.e, physical parameters, CBC, biochemistry, and thoracic radiographs), increments of 1 mg/kg twice a day of furosemide (up to 5 mg/kg, 2x/day, according to the British Specific Product Characteristicsd) for dogs from the Furosemide group and increments of 0.2 mg/kg once a day of torasemide for dogs from the Torasemide group (up to 0.8 mg/kg/d).
##Follow‐up from Day 0 to Day 84 ± 4 days: if judged necessary by the clinical investigator (depending on the animal's clinical condition and all parameters recorded at each visit (i.e, physical parameters, CBC, biochemistry, and thoracic radiographs), increments of 1 mg/kg twice a day of furosemide (up to 5 mg/kg, 2x/day, according to the British Specific Product Characteristicsd) for dogs from the Furosemide group and increments of 0.1 mg/kg once a day of torasemide for dogs from the Torasemide group (up to 0.6 mg/kg/d). The initial dose of 0.2 mg/kg once a day could also be decreased to 0.1 mg/kg once a day after Day 7.
Bidivisible tablets containing 19 and 40 mg of furosemide.
Bidivisible tablets containing 1.5, 4.5, and 12 mg of torasemide.
Bidivisible tablets containing 0.75 mg of torasemide, and quadri‐divisible tablets containing 3.0, 7.5, and 18 mg of torasemide.